Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.7268
Delayed Data
As of Mar 27
 +0.0211 / +2.99%
Today’s Change
0.28
Today|||52-Week Range
0.77
+135.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues18.8M5.6M23.4M10.7M
 
 
 
 
 
Cost of Goods Sold9.1M2.4M14.8M7.3M
 
 
 
 
 
Depreciation And Amortization614.0K613.0K606.0K631.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.1M2.5M7.9M2.8M
 
 
 
 
 
General Expenses21.0M13.6M12.0M10.6M
 
 
 
 
 
Research And Development16.3M8.6M7.0M6.0M
 
 
 
 
 
Total Operating Expenses30.7M16.7M27.4M18.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.9M-11.1M-4.1M-7.8M
 
 
 
 
 
Interest Expense On Debt0.000.00--2.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M-11.1M-4.1M-7.8M
 
 
 
 
 
Preferred Dividend-1.0M-1.4M-1.4M-1.4M
 
 
 
 
 
Net Income-11.9M-11.1M-4.1M-7.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS236.9M239.6M244.8M260.8M
 
 
 
 
 
Shares To Calculate EPS Diluted236.9M239.6M244.8M260.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.05-$0.02-$0.04
 
 
 
 
 
EPS Diluted-$0.05-$0.05-$0.02-$0.04